224 related articles for article (PubMed ID: 9240732)
21. Serum tartrate-resistant acid phosphatase 5b in monitoring bisphosphonate treatment with clodronate: a comparison with urinary N-terminal telopeptide of type I collagen and serum type I procollagen amino-terminal propeptide.
Tähtelä R; Seppänen J; Laitinen K; Katajamäki A; Risteli J; Välimäki MJ
Osteoporos Int; 2005 Sep; 16(9):1109-16. PubMed ID: 15605190
[TBL] [Abstract][Full Text] [Related]
22. The effectiveness of cyclic and continuous oral clodronate therapy on bone density and markers in osteopenic postmenopausal women.
Tsai KS; Hsu SH; Yang RS; Cheng WC; Chieng PU
Calcif Tissue Int; 1999 May; 64(5):384-8. PubMed ID: 10203414
[TBL] [Abstract][Full Text] [Related]
23. Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: a dose response study.
Brixen K; Kassem M; Nielsen HK; Loft AG; Flyvbjerg A; Mosekilde L
J Bone Miner Res; 1995 Dec; 10(12):1865-74. PubMed ID: 8619366
[TBL] [Abstract][Full Text] [Related]
24. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.
Välimäki MJ; Tiihonen M; Laitinen K; Tähtelä R; Kärkkäinen M; Lamberg-Allardt C; Mäkelä P; Tunninen R
J Bone Miner Res; 1994 May; 9(5):631-7. PubMed ID: 8053391
[TBL] [Abstract][Full Text] [Related]
25. A double-blind placebo-controlled study of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel disease.
Abitbol V; Briot K; Roux C; Roy C; Seksik P; Charachon A; Bouhnik Y; Coffin B; Allez M; Lamarque D; Chaussade S
Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1184-9. PubMed ID: 17683996
[TBL] [Abstract][Full Text] [Related]
26. Prevention of early postmenopausal bone loss with cyclical etidronate therapy (a double-blind, placebo-controlled study and 1-year follow-up).
Meunier PJ; Confavreux E; Tupinon I; Hardouin C; Delmas PD; Balena R
J Clin Endocrinol Metab; 1997 Sep; 82(9):2784-91. PubMed ID: 9284696
[TBL] [Abstract][Full Text] [Related]
27. Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis.
Khan SA; Kanis JA; Vasikaran S; Kline WF; Matuszewski BK; McCloskey EV; Beneton MN; Gertz BJ; Sciberras DG; Holland SD; Orgee J; Coombes GM; Rogers SR; Porras AG
J Bone Miner Res; 1997 Oct; 12(10):1700-7. PubMed ID: 9333131
[TBL] [Abstract][Full Text] [Related]
28. Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women.
Diamond T; McGuigan L; Barbagallo S; Bryant C
Am J Med; 1995 May; 98(5):459-63. PubMed ID: 7733124
[TBL] [Abstract][Full Text] [Related]
29. Protective effect of short-tem calcitriol or cyclical etidronate on bone loss after cardiac or lung transplantation.
Henderson K; Eisman J; Keogh A; MacDonald P; Glanville A; Spratt P; Sambrook P
J Bone Miner Res; 2001 Mar; 16(3):565-71. PubMed ID: 11277275
[TBL] [Abstract][Full Text] [Related]
30. Cyclical etidronate therapy for prevention of postmenopausal bone loss: a 1-year open-label follow-up study.
Fogelman I; Herd RJ; Blake GM; Balena R
Calcif Tissue Int; 2000 May; 66(5):348-54. PubMed ID: 10773104
[TBL] [Abstract][Full Text] [Related]
31. Effects of cyclical etidronate therapy on bone loss in early postmenopausal women who are not undergoing hormonal replacement therapy.
Pouilles JM; Tremollieres F; Roux C; Sebert JL; Alexandre C; Goldberg D; Treves R; Khalifa P; Duntze P; Horlait S; Delmas P; Kuntz D
Osteoporos Int; 1997; 7(3):213-8. PubMed ID: 9205633
[TBL] [Abstract][Full Text] [Related]
32. Comparison of calcitriol treatment with etidronate-calcitriol and calcitonin-calcitriol combinations in Turkish women with postmenopausal osteoporosis: a prospective study.
Gürlek A; Bayraktar M; Gedik O
Calcif Tissue Int; 1997 Jul; 61(1):39-43. PubMed ID: 9192511
[TBL] [Abstract][Full Text] [Related]
33. Dose-response effect of short-term calcitriol treatment on bone and mineral metabolism in normal males.
Gram J; Junker P; Nielsen HK; Bollerslev J
Bone; 1996 Jun; 18(6):539-44. PubMed ID: 8805994
[TBL] [Abstract][Full Text] [Related]
34. Prevention of early postmenopausal bone loss with cyclical etidronate.
Adami S; Bruni V; Bianchini D; Becorpi A; Lombardi P; Campagnoli C; Ferrari A; Marchesoni T; Balena R
J Endocrinol Invest; 2000 May; 23(5):310-6. PubMed ID: 10882149
[TBL] [Abstract][Full Text] [Related]
35. Effects of 8 years of treatment with tibolone 2.5 mg daily on postmenopausal bone loss.
Rymer J; Robinson J; Fogelman I
Osteoporos Int; 2001; 12(6):478-83. PubMed ID: 11446564
[TBL] [Abstract][Full Text] [Related]
36. Biochemical markers as surrogates in clinical trials in patients with metastatic bone disease and osteoporosis.
Schlosser K; Scigalla P
Scand J Clin Lab Invest Suppl; 1997; 227():21-8. PubMed ID: 9127465
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the efficacy of etidronate therapy in preventing glucocorticoid-induced bone loss in patients with inflammatory rheumatic diseases. A randomized study.
Cortet B; Hachulla E; Barton I; Bonvoisin B; Roux C
Rev Rhum Engl Ed; 1999 Apr; 66(4):214-9. PubMed ID: 10339777
[TBL] [Abstract][Full Text] [Related]
38. Tamoxifen reduces bone turnover and prevents lumbar spine and proximal femoral bone loss in early postmenopausal women.
Ward RL; Morgan G; Dalley D; Kelly PJ
Bone Miner; 1993 Aug; 22(2):87-94. PubMed ID: 8251768
[TBL] [Abstract][Full Text] [Related]
39. Bone mass and markers of bone and calcium metabolism in postmenopausal women treated with 1,25-dihydroxyvitamin D (Calcitriol) for four years.
Sairanen S; Kärkkäinen M; Tähtelä R; Laitinen K; Mäkelä P; Lamberg-Allardt C; Välimäki MJ
Calcif Tissue Int; 2000 Aug; 67(2):122-7. PubMed ID: 10920216
[TBL] [Abstract][Full Text] [Related]
40. Intravenous ibandronate injections given every three months: a new treatment option to prevent bone loss in postmenopausal women.
Stakkestad JA; Benevolenskaya LI; Stepan JJ; Skag A; Nordby A; Oefjord E; Burdeska A; Jonkanski I; Mahoney P;
Ann Rheum Dis; 2003 Oct; 62(10):969-75. PubMed ID: 12972476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]